SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chan Chun Sing on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

Click Holdings ($CLIK) is trending due to significant revenue growth and its micro-float status, drawing attention from traders seeking potential for substantial gains. Community members highlight the stock's small float and revenue increase, anticipating a potential breakout. Some are attributing the recent price action to a bot alert and solid news, while also comparing it to other low-float runners.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is trending due to community discussion around an Adweek article and its potential impact from Amazon's competitive moves in the DSP space, with many suggesting the article was misleading and reporting it to the SEC. Community members are debating the long-term value of TTD amidst competition from larger tech companies and potential market manipulation. Despite concerns, some bulls remain confident in the stock's potential, citing strong fundamentals and potential for a rebound.

Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.

Newegg Commerce Inc

NEGG is trending as retail traders discuss a potential short squeeze, with community members pointing to high borrowing costs for short sellers and a limited float. Talk centers around a large buy order that could trigger significant upward movement. Some traders are comfortable holding shares while others are looking for an entry point or taking profits.

Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. It develops the first fully implantable SynCardia TAH as an alternative to heart transplantation for patients with biventricular heart failure in the U.S. and around the world. The company is headquartered in Tucson, AZ.

Picard Medical Inc.

PMI is trending due to after-hours price action and community speculation about a potential short squeeze or upcoming news, despite the company stating they are unaware of any material changes. Traders are actively discussing potential price movements and the possibility of dilution, creating volatility. The stock's movement is also attracting attention as a potential play in the medical sector.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals is trending as the community discusses the FDA approval of their leukemia drug, Revuforj, while also noting warnings of potentially serious side effects, including differentiation syndrome and heart rhythm issues. Some see this as a buying opportunity, anticipating a future rebound, while others are concerned about the black box warning impacting physician adoption and uptake. There is also discussion of a potential buyout.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is trending due to an FDA investigation into increased reports of allergic reactions following infusions of specific lots of Immune Globulin Intravenous (IGIV), including two ADMA product lots, causing community concern and triggering a selloff. While some investors express fear and accuse manipulation, others see a buying opportunity, citing the company's fundamentals and potential pre-earnings run. The community is also discussing potential takeover bids and revenue targets.

Meet DragonWifBeard: The world's first AI-powered pet dragon!  More Than Just Scales: DragonWifBeard is a real-life bearded dragon revolutionizing the pet experience. He's not just any reptile – he's equipped with cutting-edge Eliza AI agent, giving him a unique personality and the ability to interact with his environment in unprecedented ways. The Future of Companionship: This groundbreaking project merges the love for pets with the limitless possibilities of AI. Witness the dawn of a new era in companionship with DragonWithBeard.

DragonWifBeard

DragonWifBeard ($DWB) is trending as community members highlight its potential for 'fire' and 'profits,' inviting others to join. Conversations frequently mention Solana ($SOL) and other popular cryptos, with users emphasizing the token's availability on Phantom Wallet. The discussions suggest a focus on community growth and capitalizing on the token's momentum.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is trending amid anticipation surrounding its Gen AI Summit, with discussions focusing on potential new contracts and acquisitions that could significantly impact the company's value. Community members are analyzing the event's attendees and their potential impact on Innodata's Q3 earnings, while also debating the stock's valuation and competitive positioning within the AI sector. Some analysts express bullish sentiment citing potential new contract wins, while others urge caution, highlighting the need for concrete results.

XYO is the original and one of the largest Decentralized Physical Infrastructure Networks (DePIN), boasting over 10 million nodes and consistently leading DePIN in both scale and revenue generation. Launching its Mainnet ahead of any other DePIN, XYO specializes in collecting and validating real-world data, bridging it seamlessly to Web3 and Web2 companies across AI, geolocation, and other critical data sectors. At the core of XYO are Proof of Location and Proof of Origin technologies, enabling accurate validation of real-world data for innovative use cases such as Real-World Asset (RWA) tracking, DePIN applications, real-world gaming, and treasure hunts. Recently, XYO expanded its ecosystem by launching the XYO Layer One blockchain, purpose-built to support the intensive data demands of DePIN, RWA, AI, and similar data-driven industries. XYO employs a unique dual-token model: XYO Token: An externally traded token supporting the DePIN ecosystem, rewards, staking, and governance, enhancing overall ecosystem value and scarcity.   XL1 Token: Internal to the XYO Layer One blockchain, facilitating transactions, gas fees, and other blockchain-specific use cases. The dual-token economics are strategically designed to increase scarcity and promote sustainable growth. The XYO token is available on major exchanges, including Coinbase. The XL1 token will launch publicly later in 2025. To accelerate network adoption and growth, XYO created the popular COIN app. Beyond the XYO Foundation, the team founded the U.S.-based, for-profit entity XY Labs Inc., notable as the first U.S. crypto company qualified by the SEC for a Regulation A offering, permitting share sales to both accredited and non-accredited investors. XY Labs further stands out as one of the pioneering U.S. companies to tokenize and publicly list its shares. These tokenized shares trade as $XYLB on the tZERO ATS, positioning XY Labs prominently in the growing wave of Real-World Asset (RWA) tokenization.

XYO Network

XYO Network is trending as community members debate its potential, with some expressing frustration over a lack of sustained gains and questioning the team's communication, while others remain optimistic about its long-term prospects in the decentralized physical infrastructure (DePIN) space and speculate on upcoming news or partnerships. Discussions also revolve around staking rewards and the utility of the XYO token.

Energy Fuels, Inc. is a mining development company, which engages in the exploration and evaluation of uranium and vanadium properties. It also operates the Nichols Ranch, Alta Mesa, and White Mesa Mill projects. The company was founded by George E. L. Glasier and John David Mason on June 24, 1987 and is headquartered in Lakewood, CO.

Energy Fuels Inc

Energy Fuels ($UUUU) is trending amid discussion of call option sweeps and potential government contracts related to rare earth elements. The community is speculating about insider trading and upcoming news, with some citing the company's strategic position in the sector. Some are expressing concerns about dilution and short-term volatility, while others remain bullish on the company's long-term prospects due to its strategic importance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gain Therapeutics' GT-02287 study to deliver positive findings, says Roth MKM

Gain Therapeutics' GT-02287 study to deliver positive findings, says Roth MKM...

Optimistic Outlook for Gain Therapeutics Amid Progress of GT-02287 and Successful Financing

Maxim Group analyst Jason McCarthy has maintained their bullish stance on GANX stock, giving a Buy rating today. Jason McCarthy's rating is based o...

Gain Therapeutics Advances Parkinson's Treatment in Phase 1

The latest update is out from Gain Therapeutics (GANX). Gain Therapeutics, Inc. has successfully completed the multiple ascending dose phase of its...

Gain Therapeutics, Inc. (NASDAQ:GANX) Director Jeffrey Scott Riley Acquires 30,000 Shares

Gain Therapeutics, Inc. (NASDAQ:GANX - Get Free Report) Director Jeffrey Scott Riley bought 30,000 shares of the business's stock in a transaction on Thursday, March 28th. The shares were acquired at...

Gain Therapeutics, Inc. (NASDAQ:GANX) Short Interest Update

Gain Therapeutics, Inc. (NASDAQ:GANX - Get Free Report) saw a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 156,700 shares, an...

Director Jeffrey Riley Acquires 30,000 Shares of Gain Therapeutics Inc (GANX)

Gain Therapeutics appoints Jonas Hannestad as CMO

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Medical Officer

BETHESDA, Md., April 01, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) ( Gain , or the Company ), a clinical-stage biotechnology company leading the discovery and development of...

Buy Rating Affirmed for Gain Therapeutics on Promising Parkinson's Treatment and Solid Financial Outlook

Gain Therapeutics (GANX Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram Selvaraju from...

Gain Therapeutics Reports Financial Results for Year End 2023 and Provides Corporate Update

BETHESDA, Md., March 26, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) ( Gain , or the Company ), a clinical-stage biotechnology company leading the discovery and development of...

Gain Therapeutics, Inc. is a redefining drug discovery company, which identifies and optimizes allosteric binding sites that never targeted before. Its See-Tx target identification platform uses the published 3D structure of enzymes and a proprietary computational technology to discover new allosteric binding sites and predict their druggability. The firm is also unlocking new treatment options to treat disorders characterized by protein misfolding. The company was founded by Khalid Islam in 2017 and is headquartered in Bethesda, MD.

Gain Therapeutics Inc

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Current Price	$1.98
Prev Close	$1.97
Open	$2.00
Dividend Yield	0.00%
50-Day Moving Average	$1.83
Beta	1.14
Avg. Volume	674,342.71
PE Ratio	-3.00

52-Week High	$2.81
52-Week Low	$1.41
Market Capitalization	$70.82M
EPS (Annual)	-$0.892
Price to Book	16.40
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

GANX
Gain Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GANX News

GANXGain Therapeutics Inc